EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Validation of a Pre-Transplant Risk Score (LT-MVI Score) to Predict Microvascular Invasion in Hepatocellular Carcinoma Candidates for Liver Transplantation

Quirino Lai, Timothy M Pawlik iD, Suela Ajdini, Jean Emond, Karim Halazun, Arvinder S Soin, Prashant Bhangui iD, Tomoharu Yoshizumi iD, Takeo Toshima iD, Marlene Panzer, Benedikt Schaefer iD, Maria Hoppe-Lotichius iD und 12 weitere

Cancers · 24.04.2025 · 17 (9) · 1418

DOI: 10.3390/cancers17091418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 24.04.2025. Verfasst von Quirino Lai und 23 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery and Organ Transplantation Unit, AOU Policlinico Umberto I, Sapienza University of Rome, 00185 Rome, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: MVI is a relevant prognostic factor among patients with hepatocellular carcinoma (HCC) receiving liver transplantation (LT). The preoperative assessment of the risk for MVI is relevant to pre-LT patient management and selection. The objective of this study was to create and validate a model to predict microvascular invasion (MVI) based on preoperative variables in the LT setting.

Methods

A total of 2170 patients from 11 collaborative centers in Europe, Asia, and the US, who received transplants between 1 January 2000 and 31 December 2017, were enrolled in the study. The entire cohort was split into a training and a validation set (70/30% of the initial cohort, respectively) using random selection.

Results

MVI was reported in 586 (27.0%) explanted specimens. Using the training set data, multivariable logistic regression identified three preoperative parameters associated with MVI: α-fetoprotein (lnAFP; odds ratio [OR] = 1.19; 95% confidence interval [CI] = 1.13–1.27), imaging tumor burden score (lnTBS; OR = 1.66; 95%CI = 1.39–1.99), and a fast-track approach before LT due to the availability of a live donation (OR = 1.99; 95%CI = 1.56–2.53). In the validation set, the LT-MVI c-index was 0.74, versus 0.69 for the MVI score proposed by Endo et al. (Brier Skill Score +75%). The new score had a relevant net reclassification index (overall value = 0.61). Stratifying the validation set into three risk categories (0–50th, 51st–75th, and >75th score percentiles), a very good stratification was observed in terms of disease-free (5-year: 89.3, 75.5, and 50.7%, respectively) and overall survival (5-year: 79.5, 72.6, and 53.7%, respectively).

Conclusions

The preoperative assessment of MVI using the proposed score demonstrated very good accuracy in predicting MVI after LT.

Schlagwörter

Stichwörter der Autor:innen

alpha-fetoproteinliving-donor liver transplantationrecurrencetumor burden score

Autor:innen und Institutionen

  • General Surgery and Organ Transplantation Unit, AOU Policlinico Umberto I, Sapienza University of Rome, 00185 Rome, Italy.
  • Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • The New York Presbyterian Hospital, Columbia University, New York, NY 10032, USA.
  • Department of Surgery, Division Hepatobiliary and Pancreatic Surgery, NYU Langone Medical Center, New York, NY 10006, USA.
  • Medanta Institute of Liver Transplantation and Regenerative Medicine, Medanta-The Medicity, Gurgaon 122001, India.
  • Department of Surgery and Science, Kyushu University, Fukuoka 819-0395, Japan.

ORCID-Profile: Timothy M Pawlik, Prashant Bhangui, Tomoharu Yoshizumi, Takeo Toshima, Benedikt Schaefer, Maria Hoppe-Lotichius, Jens Mittler, Etsuro Hatano, Tiffany Wong, Chao-Long Chen, Alessandro Vitale, Laurent Coubeau, Umberto Cillo

Zitieren

APA

Lai, Q., Pawlik, T. M., Ajdini, S., Emond, J., Halazun, K., Soin, A. S., Bhangui, P., Yoshizumi, T., Toshima, T., Panzer, M., Schaefer, B., Hoppe-Lotichius, M., Mittler, J., Ito, T., Hatano, E., Rossi, M., Chan, A. C. Y., Wong, T., Chen, C. L., …, & Lerut, J. P. (2025). Development and Validation of a Pre-Transplant Risk Score (LT-MVI Score) to Predict Microvascular Invasion in Hepatocellular Carcinoma Candidates for Liver Transplantation. Cancers, 17(9), 1418. https://doi.org/10.3390/cancers17091418

Vancouver

Lai Q, Pawlik TM, Ajdini S, Emond J, Halazun K, Soin AS, et al. Development and Validation of a Pre-Transplant Risk Score (LT-MVI Score) to Predict Microvascular Invasion in Hepatocellular Carcinoma Candidates for Liver Transplantation. Cancers. 2025;17(9):1418. doi:10.3390/cancers17091418

BibTeX
@article{Lai2025,
  author = {Lai, Quirino and Pawlik, Timothy M and Ajdini, Suela and Emond, Jean and Halazun, Karim and Soin, Arvinder S and Bhangui, Prashant and Yoshizumi, Tomoharu and Toshima, Takeo and Panzer, Marlene and Schaefer, Benedikt and Hoppe-Lotichius, Maria and Mittler, Jens and Ito, Takashi and Hatano, Etsuro and Rossi, Massimo and Chan, Albert C Y and Wong, Tiffany and Chen, Chao-Long and Lin, Chih-Che and Vitale, Alessandro and Coubeau, Laurent and Cillo, Umberto and Lerut, Jan P},
  title = {Development and Validation of a Pre-Transplant Risk Score (LT-MVI Score) to Predict Microvascular Invasion in Hepatocellular Carcinoma Candidates for Liver Transplantation},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {9},
  pages = {1418},
  doi = {10.3390/cancers17091418}
}
Kostenlos starten →